Straumann Holding AG represents values of innovation, excellence, and integrity in the field of dental solutions. As a leading global provider of dental implant systems, Straumann is committed to delivering high-quality products and services that improve patients' lives. The company prioritizes continuous research and development to stay at the forefront of dentistry, constantly pushing boundaries and setting new industry standards. With a customer-centric approach and a commitment to ethical practices, Straumann aims to collaborate with dental professionals and provide them with comprehensive solutions for successful treatments.

Straumann Holding AG, a renowned dental solutions provider, primarily operates in various countries and regions worldwide. The company has a strong presence in Europe, serving a significant client base across Germany, France, Switzerland, and the United Kingdom. Additionally, Straumann extends its operations to North America, with a focus on the United States and Canada. The company's global reach expands further into the Asia-Pacific region, particularly in Japan, China, and Australia. Straumann Holding AG also maintains its presence in Latin America, including Brazil and Mexico, as well as in the Middle East and Africa.

Straumann Holding AG has achieved significant milestones throughout its history. Since its establishment, the company has established itself as a global leader in dental implant and restorative dentistry solutions. Straumann has been at the forefront of innovation, introducing groundbreaking technologies and products to improve patient outcomes. The company has also expanded its market presence, growing its distribution network and establishing subsidiaries worldwide. In recent years, Straumann Holding AG has focused on strategic acquisitions and partnerships, further enhancing its portfolio and market position. These achievements have solidified Straumann's reputation as a trusted and reliable provider of dental solutions.

Straumann Holding AG, a renowned Swiss company, has a rich history and background in the field of dental implants and solutions. Established in 1954 by Reinhard Straumann, the company has grown into a global leader in oral healthcare. With relentless dedication to research, innovation, and quality, Straumann has revolutionized dental treatments and implantology. It has expanded its reach across more than 100 countries, consistently delivering state-of-the-art dental products and services. Straumann Holding AG has a strong commitment to patient care, partnering with clinicians to provide optimal dental solutions. Today, it continues to shape the future of dentistry, being a trusted name in the industry.

The main competitors of Straumann Holding AG in the market are Dentsply Sirona Inc., Zimmer Biomet Holdings, Inc., and Henry Schein, Inc.

Straumann Holding AG is primarily active in the dental industry.

The business model of Straumann Holding AG revolves around being a global leader in implant, restorative, and regenerative dentistry. With a strong focus on innovation and product development, Straumann offers a comprehensive range of solutions for dental professionals. The company provides dental implants, prosthetics, digital solutions, and biomaterials for tooth replacement and restoration. Straumann emphasizes research and clinical studies to ensure the highest quality standards and patient satisfaction. Through strategic partnerships and a strong distribution network, Straumann aims to enhance oral healthcare globally. As a recognized brand in the dental industry, Straumann Holding AG continues to drive advancements in dental technology, producing exceptional products and services.

Straumann Holding의 P/E 비율은 36.94입니다.

Straumann Holding의 P/S 비율은 6.91입니다.

Straumann Holding에 대한 AlleAktien 품질 점수는 9/10입니다.

예상되는 Straumann Holding 매출은 2.64 조. CHF입니다.

예상되는 Straumann Holding 이익은 494.49 백만 CHF입니다.

The Straumann Holding AG is a globally leading provider of innovative solutions in the field of dentistry and implantology. The company's business model is based on the manufacturing and distribution of high-quality dental implant systems, instruments, CAD/CAM prosthetic solutions, as well as complementary products and services. The company is divided into several business segments, each targeting different customer groups and needs. The most important business segment is implantology, where Straumann manufactures and distributes high-quality dental implant systems. The company's portfolio includes a wide range of implant solutions, including single tooth implants, complete dental solutions, and immediate implants. Another important business segment for Straumann is CAD/CAM prosthetics, where the company utilizes advanced digital technologies to develop individually customized prostheses and dental restorations. These state-of-the-art prosthetic solutions are supplied to both dental offices and dental laboratories. Straumann's regenerative dentistry is another significant business segment, where the company offers products and solutions to support bone formation and improve wound healing. These products are often used in conjunction with implant systems and help enhance the body's natural healing processes. In addition to these key business segments, Straumann also provides a variety of complementary products and services, including instruments, laboratory equipment, and training for dentists and dental laboratories. The company also collaborates closely with dental professionals to develop new solutions and further improve existing product lines. Overall, Straumann's business model is based on the manufacturing and distribution of top-quality products in the field of dentistry and implantology. The company has established a strong market position with a broad product range and a high level of innovation. It relies on close collaboration with its customers and constantly strives to enhance its high-quality solutions and services. Straumann Holding AG is headquartered in Basel, Switzerland and operates globally. The company employs over 5,500 employees and is listed on the Swiss SIX Swiss Exchange. With an annual revenue of over 1 billion euros, Straumann is one of the largest and most successful providers of dental implant systems worldwide.

Straumann Holding은(는) 연간 1번의 배당을 통해 0.68 CHF의 배당금을 지급합니다.

Straumann Holding는 연간 1번의 배당금을 지급합니다.

Straumann Holding의 ISIN은 CH0012280076입니다.

Straumann Holding의 WKN은 914326입니다.

Straumann Holding의 티커는 STMN.SW입니다.

지난 12개월 동안 Straumann Holding은(는) 0.8 CHF 의 배당금을 지급했습니다. 이는 약 0.7 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Straumann Holding은(는) 0.57 CHF의 배당금을 지급할 것으로 예상됩니다.

Straumann Holding의 현재 배당 수익률은 0.7 %입니다.

Straumann Holding은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Straumann Holding은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0.57 CHF의 배당금이 예상됩니다. 이는 배당수익률 0.5 %에 해당합니다.

Straumann Holding은 '건강' 섹터에 속합니다.

Straumann Holding의 마지막 배당금을 0.45 CHF만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Straumann Holding는 0.675 CHF를 배당금으로 지급했습니다.

Straumann Holding의 배당금은 CHF에 지급됩니다.